Legend Capital returned to back a $43.7m round for endoscope producer Aohua, which will use the proceeds to expand internationally.
China-based medical diagnostics device developer Aohua Endoscopy has raised RMB300m ($43.7m) in series D funding from investors including Legend Capital, the investment firm created by conglomerate Legend Holdings, China Money Network has reported.
Private equity firm Lyfe Capital led the round, investing together with venture capital firm Qiming Venture Partners.
Aohua produces endoscopes, long winding tubes with fitted cameras that are fed into a patient’s body in order to view a particular internal part and analyse the disorders with which…
